- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Loading...
IGL's board meeting approved the Q1 FY26 consolidated financial results. Revenue from operations stood at ₹25.03 Cr, with profit after tax at ₹0.73 Cr. Earnings per share were ₹23.66. The company is proceeding with its demerger scheme to separate Bio Pharma and Spirits & Biofuel businesses, with an appointed date of April 1, 2026. This move aims to unlock value for stakeholders. Additionally, a stock split was approved, converting each ₹10 face value share into two ₹5 shares, effective August 12, 2025. This will double the number of outstanding shares.